Microbial cell membranes and surface biomolecules

Microbial cell membranes and surface biomolecules are critical structural components that maintain the integrity and viability of bacteria, fungi, and viruses (Source: StatPearls, "Antibiotics"). In bacteria, the cell wall (peptidoglycan) and membranes (inner and outer) serve as protective barriers and sites for essential processes like nutrient transport and energy generation (Source: Nature Reviews Microbiology, "How antibiotics kill bacteria"). Fungal membranes are characterized by the presence of ergosterol, a sterol not found in human cells, making it a primary target for antifungal agents like polyenes and azoles (Source: Journal of Antimicrobial Chemotherapy, "Antifungal agents: mechanisms of action"). Drugs targeting these structures, such as beta-lactams, glycopeptides, and polymyxins, work by either inhibiting the synthesis of the cell wall or directly disrupting membrane stability, leading to rapid microbial death (Source: NIH, "Antimicrobial Resistance"). While highly effective, targeting these broad structures can lead to significant safety concerns, including nephrotoxicity and the emergence of multi-drug resistant organisms (Source: Clinical Microbiology Reviews, "Polymyxins: Antibiotics of Last Resort"). These targets are fundamental to infectious disease management, as they allow for selective toxicity against pathogens while sparing host cells.

Other names

Microbial envelopeBacterial cell wallFungal cell membraneSurface antigensExtracellular matrix componentsBacterial outer membrane

Drugs targeting these structures act by inhibiting the synthesis of essential cell wall polymers (e.g., peptidoglycan, beta-glucan), directly disrupting the physical integrity of the lipid bilayer, or inhibiting the synthesis of unique membrane sterols like ergosterol, ultimately leading to cell lysis and death.